Wi-Fi, Smartphones, and Surveillance: The New Face of Schizophrenia Delusions
December 18, 2025
Brand Name :
No Data Available.
Synonyms :
chloral hydrate
Class :
Sedative or Hypnotics
Dosage Forms & Strengths
Capsule
500 mg
Syrup
500mg/5ml
Take a dose of 500 mg to 1 g orally 15 to 30 minutes before sleep
Only for use up to 2 weeks and a daily dose not more than 2 g
Take a dose of 250 mg orally after meals every 8 hours and daily dose not more than 2 g
Dosing modification
Renal Impairment
Not recommended
Hepatic Impairment
Not recommended
Administration
When the patient has been consistently taking high doses of the medication for extended periods of time
It is recommended to gradually reduce the dosage over a period of two weeks before completely discontinuing
Dosage Forms & Strengths
Capsule
500 mg
Syrup
500mg/5ml
Take a dose of 50 to 75 mg/kg orally, 30 to 60 min prior to procedure and this may be repeated in half an hour, if required
Dose should not be more than 1 g in infants and 2 g in children
Take 25 to 50 mg/kg daily orally divided every 6 to 8 hours and dose not more than 500 mg
Refer to adult dosing
chloral hydrate: they may increase the CNS depressant effect of CNS Depressants
chloral hydrate: they may increase the CNS depressant effect of CNS Depressants
chloral hydrate: they may increase the CNS depressant effect of CNS Depressants
chloral hydrate: they may increase the CNS depressant effect of CNS Depressants
chloral hydrate: they may increase the CNS depressant effect of CNS Depressants
chloral hydrate leads to a reduction in the rate of excretion of pentaerythritol tetranitrate, which leads to an increased level of serum
chloral hydrate may decrease the excretion rate of almasilate, leading to higher serum levels
It may enhance the risk of adverse effects when combined with Hypnotics
pneumococcal vaccine 13-valent
It may enhance the risk of adverse effects when combined with Hypnotics
pneumococcal vaccine heptavalent
It may enhance the risk of adverse effects when combined with Hypnotics
pneumococcal vaccine polyvalent
It may enhance the risk of adverse effects when combined with Hypnotics
cinnarizine and dimenhydrinate
this combination will make you feel sleepy or tired when Tranquillisers used in combination
chloral hydrate might lead to a reduction in the rate of excretion of telavancin, potentially leading to elevated levels of serum
Actions and Spectrum
As it reduces brain and spinal cord activity, chloral hydrate predominantly has a depressive effect on the central nervous system. GABA is an inhibitory neurotransmitter that helps control neuronal activity.
chloral hydrate has a wide range of effects, including sedative, hypnotic, anxiolytic (anti-anxiety), and anticonvulsant properties.
Frequency not defined
Cardiovascular: Atrial arrhythmia, hypotension, shortening of refractory periods, depression of myocardial contractility
Gastrointestinal: Diarrhea, nausea, vomiting, flatulence, gastric irritation
Hematologic and oncologic: Acute porphyria, leukopenia, eosinophilia
Ophthalmic: Allergic conjunctivitis, blepharoptosis, keratoconjunctivitis
Dermatologic: Skin rash
Otic: Increased middle ear pressure
Respiratory: Airway obstruction (young children), laryngeal edema (children)
Central nervous system: Abnormal gait, ataxia, confusion, hallucinations, hangover effect, malaise, nightmares, delirium, dizziness, drowsiness, drug dependence
Endocrine and metabolic: Acute porphyria, ketonuria
Black Box Warning
None
Contraindication/Caution:
Contraindication:
Caution:
Pregnancy consideration:
Pregnancy category: N/A
Lactation: It present into human milk
Pregnancy Categories:
Category A: well-controlled and Satisfactory studies show no risk to the fetus in the first or later trimester.
Category B: there was no evidence of risk to the fetus in animal studies, and there were not enough studies on pregnant women.
Category C: there was evidence of risk of adverse effects in animal reproduction studies, and no adequate evidence in human studies must take care of potential risks in pregnant women.
Category D: adequate data with sufficient evidence of human fetal risk from various platforms, but despite the potential risk, and used only in emergency cases for potential benefits.
Category X: Drugs listed in this category outweigh the risks over benefits. Hence these categories of drugs need to be avoided by pregnant women.
Category N: There is no data available for the drug under this category.
Pharmacology
Trichloroethanol is the active metabolite responsible for the pharmacological effects of chloral hydrate.
Trichloroethanol acts primarily as a central nervous system depressant. It enhances the inhibitory effects of gamma-aminobutyric acid (GABA), an inhibitory neurotransmitter in the brain.
Pharmacodynamics
GABA is the major inhibitory neurotransmitter in the central nervous system. By enhancing the effects of GABA, chloral hydrate increases the opening frequency of GABA-gated chloride channels.
Pharmacokinetics
Absorption
Its absorption occurs in the gastrointestinal tract after oral administration.
Distribution
It distributes throughout the body.
Metabolism
chloral hydrate is metabolized in the liver through the enzyme alcohol dehydrogenase.
Elimination and excretion
The metabolites of chloral hydrate are excreted primarily in the urine.
Administration
chloral hydrate is administered orally in the form of a syrup (solution) and capsule.
Patient information leaflet
Generic Name: chloral hydrate
Why do we use chloral hydrate?
chloral hydrate was commonly used as a sedative to induce sleep or relaxation in patients.
chloral hydrate has been used in pediatric settings to facilitate sedation for diagnostic procedures, such as imaging studies.